News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi-Aventis (France) (SASY.PA) Stops Development of Two Drugs: Eplivanserin in Insomnia and Thrombosis Drug Idrabiotaparinux


12/21/2009 6:56:09 AM

Bookmark and Share

Reuters -- French drugmaker Sanofi-Aventis stopped developing two medicines as part of an overhaul of its research and development portfolio, saying they would not bring significant benefits.

Read at Reuters
Read at Bloomberg

comments powered by Disqus
Reuters
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES